References
- Bartalena L, Baldeschi L, Dickinson A, et al. Consensus statement of the European Group on Graves’ orbitopathy (EUGOGO) on management of GO. Eur J Endocrinol. 2008;158(3):273–285.
- Mf P, Mn G, Fw Z, Wiersinga WM. The usefulness of quantitative orbital magnetic resonance imaging in Graves’ ophthalmopathy. Clin Endocrinol (Oxf). 2001;54(2):205–209.
- Mourits MP, Prummel MF, Wiersinga WM, Koornneef L. Clinical activity score as a guide in the management of patients with Graves’ ophthalmopathy. Clin Endocrinol (Oxf). 1997;47(1):9–14.
- Tortora F, Cirillo M, Ferrara M, et al. Disease activity in Graves’ ophthalmopathy: diagnosis with orbital MR imaging and correlation with clinical score. Neuroradiol J. 2013;26:555–564.
- Hoh HB, Laitt RD, Wakeley C, et al. The STIR sequence MRI in the assessment of extraocular muscles in thyroid eye disease. Eye (Lond). 1994;8(Pt 5):506–510.
- Mayer E, Herdman G, Burnett C, Kabala J, Goddard P, Potts MJ. Serial STIR magnetic resonance imaging correlates with clinical score of activity in thyroid disease. Eye (Lond). 2001;15(Pt 3):313–318.
- Tortora F, Prudente M, Cirillo M, et al. Diagnostic accuracy of short-time inversion recovery sequence in Graves’ ophthalmopathy before and after prednisone treatment. Neuroradiology. 2014;56:353–361.
- Politi LS, Godi C, Cammarata G, et al. Magnetic resonance imaging with diffusion-weighted imaging in the evaluation of thyroid-associated orbitopathy: getting below the tip of the iceberg. Eur Radol. 2014;24:1118–1126.
- Ritchie AE, Lee V, Feeney C, Lingam RK. Using Nonechoplanar Diffusion-weighted MRI to assess treatment response in Active Graves Orbitopathy: a novel approach with 2 case reports. Opthal Plast Reconstr Surg. 2016;32(3):e67–70.
- Kilicarslan R, Alkan A, Ilhan MM, et al. Grave’s ophthalmopathy: the role of diffusion-weighted imaging in detecting involvement of extraocular muscles in early period of disease. Bjr. Mar 2015;88(1047):21040677.
- Mohaseb K, Linder M, Rootman J, et al. Development and validation of a patient symptom questionnaire to facilitate early diagnosis of thyroid – associated orbitopathy in Grave’s disease. Orbit. 2008;27(6):419–425.
- Kahaly GJ, Pitz S, Hommel DM. Randomized, Single blind trial of intravenous versus oral steroid monotherapy in Grave’s Orbitopathy. J Clin Endocrinol Metab. 2005;90(9):5234–5240.
- Duntas LH, Benvenga S. Selenium: an element for life. Endocrine. Apr 2015;48(3):756–775.
- Khemani S, Singh A, Lingam RK, Kalan A. Imaging of postoperative middle ear cholesteatoma. Clin Radiol. 2011;66(8):760–767.
- Lingam RKL, Khatri P, Hughes J, Singh A. Apparent diffusion coefficients for detection of postoperative middle ear cholesteatoma on non–echo-planar diffusion-weighted Images. Radiology. 2013;269(2):504–510.
- Padani AR, Liu G, Mu-Koh D, et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and Recommendations. Neoplasia. 2009;11(2):102–125.
- Kolff-Gart AS, Pouwels DP, Noji R, et al. Diffusion-weighted imaging of the head and neck in healthy subjects: reproducibility of ADC values in different MRI systems and repeat sessions. Ajnr. 2015; 36:384–390.